When reactivated against a number of tumor cell lines expressing mesothelin, the function of CAR Type 17 cells was raised compared to ROR agonist-untreated cells, and they released more cytokines, including IL17A and IFN [129]. The gene discussed is LINC-ROR; the disease is neoplasm.